Neurocare Group Receives FDA Clearance for Its Industry-Leading Intermittent Theta Burst Stimulation (iTBS) Protocol for Transcranial Magnetic Stimulation (TMS)
neurocare is pleased to announce that it has received FDA clearance for its industry-leading intermittent Theta Burst Stimulation (iTBS) protocol, available across its Apollo TMS Therapy System and other Transcranial Magnetic Stimulation systems for clinical practice.ATLANTA, GA / ACCESSWIRE / August 22, 2024 / neurocare group ("neurocare" or the "Company"), a leading innovator in personalized mental health and performance, is pleased to...
Read more








